Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 2.500
+0.245 (10.86%)
Dec 31, 2025, 1:59 PM GMT+1
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of 7.38 million as of December 31, 2025. Its market cap has decreased by -6.72% in one year.
Market Cap
7.38M
Enterprise Value
22.51M
Revenue
4.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.50
Market Cap Chart
Since September 17, 1997, Proteome Sciences's market cap has decreased from 27.59M to 7.38M, a decrease of -73.25%. That is a compound annual growth rate of -4.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 7.38M | -26.47% |
| Dec 31, 2024 | 10.04M | -24.94% |
| Dec 29, 2023 | 13.37M | 29.43% |
| Dec 30, 2022 | 10.33M | -31.71% |
| Dec 31, 2021 | 15.13M | 32.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.85B |
| GSK plc | 73.21B |
| Haleon | 33.38B |
| Smith & Nephew | 10.52B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.43B |
| HUTCHMED (China) | 1.79B |
| Genus | 1.74B |